Treatment of medication overuse headache—A review
- 1 February 2019
- journal article
- review article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 139 (5) , 405-414
Abstract
Medication overuse headache (MOH) is the most prevalent chronic headache disorder with a prevalence between 1‐2% worldwide. The disease has been acknowledged for almost 30 years, yet experts still disagree on how best to treat MOH. By performing a search in PubMed on the terms “medication overuse headache”, “analgesics abuse headache”, “rebound headache”, “drug induced headache”, and “headache AND drug misuse” limited to human studies published in English between January 1st 2004 and November 1st 2017, we aimed to evaluate current literature concerning predictors of treatment outcome, inpatient and outpatient treatment programs, initial versus latent administration of prophylactic medications, and to review the effect of prophylactic medications. Selection criteria were prospective, comparative or controlled trials on treatment of MOH in persons of at least 18 years of age. Several studies evaluated risk factors to predict the outcome of MOH treatment, but many studies were underpowered. Psychiatric comorbidity, high dependence score and overuse of barbiturates, benzodiazepines and opioids predicted a poorer outcome of withdrawal therapy. Patients with these risk factors benefit from inpatient treatment, whereas patients without risk factors benefit equally from in and outpatient treatment. Some medications for migraine prophylactics have shown better effect on MOH compared with placebo, but not when combined with withdrawal. We conclude that detoxification programs are of great importance in MOH treatment. Latent administration of prophylactic medications reduces the number of patients needing prophylactic medication. Individualizing treatment according to the predictors of outcome may improve treatment outcome and thus reduce work‐related and treatment‐related costs.Keywords
This publication has 55 references indexed in Scilit:
- Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trialThe Journal of Headache and Pain, 2013
- Drug-dependence behaviour and outcome of medication-overuse headache after treatmentThe Journal of Headache and Pain, 2012
- Dependence scores predict prognosis of medication overuse headache: A prospective cohort from the Akershus study of chronic headachePain, 2012
- Treatment of medication overuse headache - guideline of the EFNS headache panelEuropean Journal of Neurology, 2011
- A randomized controlled trial on medication-overuse headache: outcome after 1 and 4 yearsActa Neurologica Scandinavica, 2011
- Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group studyThe Journal of Headache and Pain, 2011
- A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre studyThe Journal of Headache and Pain, 2011
- Risk factors in medication-overuse headache: A 1-year follow-up study (care II protocol)Cephalalgia, 2009
- The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headacheJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Management of Medication Overuse Headache: 1-Year Randomized Multicentre Open-Label TrialCephalalgia, 2009